Nuvation Bio (Nuvation Bio) Net Issuance of Preferred Stock : $0.00 Mil (TTM As of Sep. 2021)

View and export this data going back to 2020. Start your Free Trial

What is Nuvation Bio Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

Nuvation Bio's net issuance of preferred for the three months ended in Sep. 2021 was $0.00 Mil. The number is 0, which means that Nuvation Bio has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

Nuvation Bio's net issuance of preferred for the trailing twelve months (TTM) ended in Sep. 2021 was $0.00 Mil.

Nuvation Bio Net Issuance of Preferred Stock Historical Data

The historical data trend for Nuvation Bio's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuvation Bio Net Issuance of Preferred Stock Chart

Nuvation Bio Annual Data

Trend

Dec20

Dec21

Net Issuance of Preferred Stock

Nuvation Bio Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21
Net Issuance of Preferred Stock	Get a 7-Day Free Trial			-	-	-	-	-

Nuvation Bio Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Sep. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Nuvation Bio Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of Nuvation Bio's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Nuvation Bio (Nuvation Bio) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuvation Bio Inc (NYSE:NUVB) » Definitions » Net Issuance of Preferred Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

1500 Broadway, Suite 1401, New York, NY, USA, 10036

Website

https://www.nuvationbio.com

Nuvation Bio Inc is a biopharmaceutical company. The company is engaged in developing therapeutic candidates for the unmet needs in oncology. The firm operates in pharmaceutical, biotechnology and other related markets that develop small molecules and drug conjugates as treatments for cancer patients.